Effect of human immunodeficiency virus type 1 on intracellular activation and superoxide production by neutrophils

Journal of Infectious Diseases

Volumn 180, Issue 1, 1999, Pages 206-210

  Muñoz, José F ^a   Salmen, Siham ^a   Berrueta, Lisbeth R ^a   Carlos, Maria P ^c   Cova, José A ^a   Donis, José H ^b   Hernández, Manuel R ^a   Torres, José V ^c  

^a Clinical Institute of Immunology   (Venezuela)

^b UNIVERSIDAD DE LOS ANDES   (Venezuela)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C; SUPEROXIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE FUNCTION; MALE; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ADOLESCENT; ADULT; FEMALE; GENE PRODUCTS, ENV; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; PEPTIDE FRAGMENTS; PHAGOCYTOSIS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTORS, FC; SUPEROXIDES;

EID: 0032977079     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314821     Document Type: Article

References (15)

1. Valone FH, Payan DG, Abrams DI, Goetzl EJ. Defective polymorphonuclear leukocyte chemotaxis in homosexual men with persistent lymph node syndrome. J Infect Dis 1984;150:267-71.
2. Gabrilovich DI, Kozhich AT, Suvorora ZK, et al. Influence of HIV antigens on functional activity of neutrophilic granulocytes. Scand J Immunol 1991;33:549-52.
3. Chen TP, Roberts RL, Wu KG, Stiehm ER. Decreased superoxide anion and hydrogen peroxide production by neutrophils and monocytes in human immunodeficiency virus infected children and adults. Pediatr Res 1993; 34:544-50.
4. Pinching AJ. The acquired immune deficiency syndrome. Clin Exp Immunol 1984;56:1-13.
5. Bondestam M, Hakansson L, Foucard T, Venge P. Defects in polymorphonuclear neutrophil function and susceptibility to infection in children. Scand J Clin Lab Invest 1986;46(7):685-94.
6. Simberkoff MS, Leaf HL. Bacterial infections in patients with HIV infection. In: Wormser GP, ed. AIDS and other manifestations of HIV infection. 2nd ed. New York: Raven Press, 1992:269-75.
7. Centers for Disease Control and Prevention. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MWWR Morb Mortal Wkly Rep 1987;36(Suppl 1):1S-15S.
8. Southwick FS, Stossel TP. Phagocytosis. In: Rose NR, Friedman H, Fahey JL, eds. Manual of clinical laboratory immunology. 3rd ed. Washington, DC: American Society for Microbiology. 1986:326-31.
9. Metcalf JA, Gallin JI, Nauseff WM, et al. Laboratory manual of neutrophil function. New York: Raven Press, 1986:2-6.
10. Dunn PA, Tyrer HW. Quantitation of neutrophil phagocytosis using fluorescent latex beads: correlation of microscopy and flow cytometry. J Lab Clin Med 1981;98:374-81.
11. Virella G, Thompson T, Haskill-Strowd R. A new quantitative nitroblue tetrazolium reduction assay based on kinetic colorimetry. J Clin Lab Anal 1990;4:86-9.
12. Anderson DE, Malley A, Benjamini E, et al. Hypervariable epitope constructs as a means of accounting for epitope variability. Vaccine 1994;12:736-40.
13. Bennett PA, Finan PM, Doxon RJ, Kellie S. Tyrosine phosphatase antagonist induced activation of neutrophil NADPH oxidase: a possible role for protein kinase C. Immunology 1995;85:304-10.
14. Al-Shami A, Gilbert C, Barabe F, et al. Preservation of the pattern of tyrosine phosphorylation in human neutrophil lysates. J Immunol Methods 1997;202:183-91.
15. Siegel JN. Antiphosphotyrosine blotting. In: Colligan JE, Kruisbeek AM, Margulies DH, et al., eds. Current protocols in immunology. Vol 3. New York: John Wiley and Sons, 1992;11.3-11.34.